Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Abcellera Biologics On Sept 18 Took Ownership Of Antibody Drug Candidate That Was Discovered By Co As Part Of Its Collaboration With EQRX; Advancing Antibody Drug Candidate Into Ind-enabling Studies

Author: Charles Gross | October 13, 2023 06:08am

-8-K

Posted In: ABCL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist